Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Fortis Healthcare Ltd.	Q V+ PT	66,059 Mid Cap	904 (0.78%)	64.62	6.66	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Metropolis Healthcare Ltd.	Q V PT	12,396 Small Cap	595.75 (0.18%)	61.19	7.91	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Concord Biotech Ltd.	Q V PT	15,629 Small Cap	1,544.65 (-2.28%)	60.05	7.98	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Yatharth Hospital & Trauma Care Services Ltd.	Q V+ PT	10,992 Small Cap	1,134 (0.96%)	59.74	5.93	39.48	45.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Gufic Biosciences Ltd.	Q V PT	4,368 Small Cap	443 (1.68%)	59.48	6.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Granules India Ltd.	Q V+ PT	23,868 Small Cap	861.35 (-1.61%)	59.27	5.81	2.07	-5.88	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Dr. Lal Pathlabs Ltd.	Q V PT	31,822 Small Cap	1,918.80 (0.13%)	59.04	12.5	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Neuland Laboratories Ltd.	Q V+ PT	29,349 Small Cap	22,740 (0.62%)	58.25	14.35	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Ind-Swift Laboratories Ltd.	Q V+ PT	3,245 Small Cap	409.95 (7.44%)	57.88	2.22	-6.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Poly Medicure Ltd.	Q V PT	17,513 Small Cap	1,713.50 (0.63%)	54.78	5.42	18.98	16.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Kopran Ltd.	Q V+ PT	1,342 Small Cap	272.15 (-3.85%)	54.75	2.55	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,195 Small Cap	1,396 (3.60%)	51.69	7.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Thyrocare Technologies Ltd.	Q V+ PT	8,848 Small Cap	589.15 (3.08%)	51.6	14.45	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Bliss GVS Pharma Ltd.	Q V+ PT	7,235 Small Cap	687.75 (4.59%)	51.34	5.67	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Rainbow Childrens Medicare Ltd.	Q V PT	14,770 Small Cap	1,429.45 (-0.76%)	51.26	8.57	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Suraksha Diagnostic Ltd.	Q V PT	1,750 Small Cap	354 (1.24%)	50.87	7.1	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Senores Pharmaceuticals Ltd.	Q V+ PT	6,474 Small Cap	1,380.60 (-0.74%)	50.69	6.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Anlon Healthcare Ltd.	Q V+ PT	1,219 Small Cap	28.97 (9.73%)	49.21	4.81	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Mankind Pharma Ltd.	Q V PT	95,744 Mid Cap	2,463.50 (1.38%)	49.13	5.96	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,606 Small Cap	3,700 (-3.57%)	49.12	11.17	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Jupiter Life Line Hospitals Ltd.	Q V PT	9,184 Small Cap	277.90 (0.69%)	48.23	5.72	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Morepen Laboratories Ltd.	Q V+ PT	6,625 Small Cap	119.65 (-2.21%)	47.71	5.15	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Park Medi World Ltd.	Q V PT	12,187 Small Cap	282.55 (-0.74%)	47.63	5.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Narayana Hrudayalaya Ltd.	Q V PT	39,437 Mid Cap	1,906 (0.51%)	47.49	8.16	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Jubilant Pharmova Ltd.	Q V+ PT	16,998 Small Cap	1,055.55 (0.58%)	47.47	2.34	6.31	-7.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Artemis Medicare Services Ltd.	Q V+ PT	5,358 Small Cap	340.90 (0.83%)	47.09	5.97	21.50	83.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Sigachi Industries Ltd.	Q V PT	1,130 Small Cap	31.11 (-0.03%)	46.9	2.24	28.55	16.06	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Blue Jet Healthcare Ltd.	Q V PT	10,887 Small Cap	583.95 (0.75%)	46.7	4.9	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	48,312 Mid Cap	2,873.05 (0.32%)	45.42	19.25	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Akums Drugs & Pharmaceuticals Ltd.	Q V+ PT	12,339 Small Cap	817.35 (-0.47%)	44.31	3.78	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Together, the businesses will focus on expanding the brand’s footprint into new geographies while gradually strengthening its omnichannel capabilities

Sep, 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Acquires 26% Stake in ?300 Crore-Valued Goodman Vetcare Pvt. Ltd., One of India’s Longest-Standing Dedicated Pet Pharmacies’ issued by the company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Park Medi World informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Park Medi World has informed that it enclosed Press Release titled ‘Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026’. The above disclosure is also being made available on the website of the Company at https://www.parkhospital.in/.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Anlon Healthcare incorporates subsidiary in Nigeria

This subsidiary will provide access to 16 Western African Countries via its local entity

Sep, 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Concord Biotech informs about board meeting

Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, September 23, 2026 to consider the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company. Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Clause 9 of the Code for Prevention of Insider Trading in the securities of the Company, the company has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today i.e. September 19, 2026 till 48 hours after the declaration of outcome of Board Meeting. The trading window shall be opened with effect from September 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Orchid Pharma Ltd.	5,923 Crore
2	Biocon Ltd.	62,743 Crore
3	Healthcare Global Enterprises Ltd.	10,580 Crore
4	Indoco Remedies Ltd.	2,302 Crore
5	Aster DM Quality Care Ltd.	65,885 Crore
6	Cohance Lifesciences Ltd.	16,760 Crore
7	Dishman Carbogen Amcis Ltd.	2,672 Crore
8	Tarsons Products Ltd.	1,631 Crore
9	Krishna Institute of Medical Sciences Ltd	34,063 Crore
10	Sai Parenterals Ltd.	2,257 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Fredun Pharmaceuticals informs about press release

Park Medi World informs about press release

Anlon Healthcare incorporates subsidiary in Nigeria

Anlon Healthcare informs about incorporation of subsidiary

Concord Biotech informs about board meeting

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?